These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25393628)

  • 21. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ammonium ion level in serum affects doxorubicin release from liposomes.
    Shibata H; Saito H; Yomota C; Kawanishi T
    Pharmazie; 2010 Apr; 65(4):251-3. PubMed ID: 20432619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.
    Gubernator J; Chwastek G; Korycińska M; Stasiuk M; Grynkiewicz G; Lewrick F; Süss R; Kozubek A
    J Control Release; 2010 Aug; 146(1):68-75. PubMed ID: 20510316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
    Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.
    Romberg B; Metselaar JM; Baranyi L; Snel CJ; Bünger R; Hennink WE; Szebeni J; Storm G
    Int J Pharm; 2007 Mar; 331(2):186-9. PubMed ID: 17145145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum.
    Han HD; Shin BC; Choi HS
    Eur J Pharm Biopharm; 2006 Jan; 62(1):110-6. PubMed ID: 16183268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
    ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
    Parr MJ; Masin D; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: preparation, characterisation, and biological evaluation.
    Turánek J; Kosztyu P; Turánek Knötigová P; Bartheldyová E; Hubatka F; Odehnalová N; Mikulík R; Vaškovicová N; Čelechovská H; Kratochvílová I; Fekete L; Tavares MR; Chytil P; Raška M; Etrych T
    Int J Pharm; 2024 Aug; 661():124465. PubMed ID: 39004290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
    Tagami T; May JP; Ernsting MJ; Li SD
    J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes.
    Ishihara A; Yamauchi M; Kusano H; Mimura Y; Nakakura M; Kamiya M; Katagiri A; Kawano M; Nemoto H; Suzawa T; Yamasaki M
    Int J Pharm; 2010 May; 391(1-2):237-43. PubMed ID: 20298767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.
    Efthimiadou EK; Tapeinos C; Chatzipavlidis A; Boukos N; Fragogeorgi E; Palamaris L; Loudos G; Kordas G
    Int J Pharm; 2014 Jan; 461(1-2):54-63. PubMed ID: 24286923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats.
    Wang JC; Liu XY; Lu WL; Chang A; Zhang Q; Goh BC; Lee HS
    Eur J Pharm Biopharm; 2006 Jan; 62(1):44-51. PubMed ID: 16126379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
    Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM; Devarajan PV
    Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.